Press release
Anthrax Key Players : Altimmune Inc, Aphios Corp, Crestone Inc, Green Cross Corp, Hawaii Biotech Inc, iBio Inc, Syntiron LLC Market Analysis and Forecast 2018-2022
Anthrax
Overview
Anthrax is a serious infectious disease caused by Bacillus anthraces. Signs and symptoms include nausea, vomiting, abdominal pain, headache, and loss of appetite, fever, severe, bloody diarrhea in the later stages of the disease, sore throat and difficulty swallowing. Risk factors include inject illegal drugs, handle animal skins and work in veterinary medicine, especially dealing with livestock.
It is primarily a disease of grazing animals such as cattle, sheep, goats, and horses. Pigs are more resistant, as are dogs and cats. Birds usually are naturally resistant to anthrax. Buzzards and vultures are naturally resistant to anthrax but may transmit the spores on their talons and beaks.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811468-anthrax-pipeline-review-h1-2018
Anthrax Industry Major Highlights:
Anthrax - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Anthrax (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases
The report further guide in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Anthrax (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Apart from this various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Major Outlook for Anthrax Report:
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Anthrax (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Anthrax (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Anthrax (Infectious Disease).
The pipeline guide provides a snapshot of the global therapeutic landscape of Anthrax (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Anthrax (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
Competitive Analysis for Anthrax
Key players are making innovative developments in Anthrax industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.
The key players in this market are ActiveSite Pharmaceuticals Inc, Coherus BioSciences Inc, Lupin Ltd, Mabion SA, OMEICOS Therapeutics GmbH, Promedior Inc, Taiwan Liposome Company Ltd and Xbrane Biopharma AB.
….. Continued
Table of Contents
Introduction 5
Global Markets Direct Report Coverage 5
Anthrax - Overview 6
Anthrax - Therapeutics Development 7
Pipeline Overview 7
Pipeline by Companies 8
Products under Development by Companies 10
Anthrax - Therapeutics Assessment 11
Assessment by Target 11
Assessment by Mechanism of Action 13
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Anthrax - Companies Involved in Therapeutics Development 19
ActiveSite Pharmaceuticals Inc 19
Coherus BioSciences Inc 19
Lupin Ltd 20
Mabion SA 20
....
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811468-anthrax-pipeline-review-h1-2018
Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anthrax Key Players : Altimmune Inc, Aphios Corp, Crestone Inc, Green Cross Corp, Hawaii Biotech Inc, iBio Inc, Syntiron LLC Market Analysis and Forecast 2018-2022 here
News-ID: 932208 • Views: …
More Releases from WISE GUY RESEARCH CONSULTANTS PVT. LTD.
CBD Snack Market 2020- Global Industry Analysis, By Key Players, Segmentation, T …
Summary:
A new market study, titled “Discover Global CBD Snack Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
Introduction
“CBD Snack Market”
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and…
Chronic Lymphocytic Leukemia Global Key Players 4SC AG, AbbVie Inc, Baliopharm A …
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2017”
Chronic lymphocytic leukemia (CLL)
Overview
Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms usually develop slowly. Symptoms of CLL include abnormal bruising (if platelets are low), fever, infections…
Onychomycosis (Tinea Unguium) Global Key Players Almirall SA, Blueberry Therapeu …
WiseGuyReports.com with their unique quality of simplifying the market research study presents a deep diving study report “Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018”
Onychomycosis (Tinea Unguium)
Overview
Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and…
Non Alcoholic Fatty Liver Disease Global Key Players Akcea Therapeutics Inc, Bet …
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018”
Non Alcoholic Fatty Liver Disease (NAFLD)
Overview
Non Alcoholic Fatty Liver Disease (NAFLD) this situation arise when individual have too much fats there your liver. There should be little or no fat in a healthy liver and for most people, carrying a small amount of…
More Releases for Anthrax
Rising Infectious Diseases Fueling Growth In The Anthrax Vaccine Market: Key Fac …
The Anthrax Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anthrax Vaccine Market Size During the Forecast Period?
The anthrax vaccine market has grown strongly, expected to rise from $11.27 billion in 2024 to $11.88 billion in 2025 at a CAGR…
Prominent Anthrax Vaccine Market Trend for 2025: Advancements And FDA Approvals …
What combination of drivers is leading to accelerated growth in the anthrax vaccine market?
The increasing frequency of infectious diseases is projected to accelerate the expansion of the anthrax vaccine market. These diseases are brought about by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can be transmitted directly or indirectly among individuals. The infection severity can range from mild to intense or even fatal, depending on the pathogen…
Rising Infectious Diseases Fueling Growth In The Anthrax Vaccine Market: A Key F …
What Are the Projections for the Size and Growth Rate of the Anthrax Vaccine Market?
The market for the anthrax vaccine has experienced a significant expansion in the past few years. Its market size is projected to increase from $11.27 billion in 2024 to $11.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.4%. The historical increase can be linked to factors such as worries about biological warfare,…
Anthrax Therapeutics Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Anthrax Therapeutics Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The inserts and dividers market is experiencing significant growth, driven by the increasing need for organization and protection in packaging across various sectors, including retail,…
Anthrax Vaccine Market Size, Demand, Share and Trends to 2030
As demonstrated by Precision Business Insights (PBI), the latest report, the global Anthrax Vaccine Market was valued at USD 32.6 million in 2023 and is poised to grow at a CAGR of 3.1% from 2024-2030. The key drivers for the growth of the global Anthrax Vaccine market include bioterrorism threats, military necessity, heightened awareness, and technological advancements.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-anthrax-vaccine-market
The Anthrax Vaccine…
Anthrax Vaccines Market to Witness Robust Expansion by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anthrax Vaccines market.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against…
